# Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus

> **NCT01500265** · — · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 216 (actual)

## Conditions studied

- Hepatitis B
- Renal Failure With Tubular Necrosis

## Interventions

- **BIOLOGICAL:** plasma and urine samples, sample with ADN

## Key facts

- **NCT ID:** NCT01500265
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-12
- **Final completion:** 2015-12
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2016-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500265, "Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01500265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*